We recommend electrical or pharmacologic cardioversion for restoration of sinus rhythm in patients with AF or AFL who are selected for rhythm-control therapy and are unlikely to convert spontaneously. (Recommendation Strong, Quality Low)

We recommend pretreatment with antiarrhythmic drugs prior to electrical cardioversion in patients who have had AF recurrence postcardioversion without antiarrhyth- mic drug pretreatment. (Recommendation Strong, Quality Moderate)

Values and preferences: These recommendations place a high value on the decision of individual patients to pursue a rhythm-control strategy for improvement in QOL and functional capacity.